MedPath
FDA Approval

Mupirocin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
April 16, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Mupirocin(20 mg in 1 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Travis County Healthcare District

Central Texas Community Health Centers

797039398

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mupirocin

Product Details

NDC Product Code
76413-158
Application Number
ANDA090480
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
July 12, 2017
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACT
MupirocinActive
Code: D0GX863OA5Class: ACTIBQuantity: 20 mg in 1 g
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5PClass: IACT
© Copyright 2025. All Rights Reserved by MedPath